4.8 Article

EASL Recommendations on Treatment of Hepatitis C 2016

Journal

JOURNAL OF HEPATOLOGY
Volume 66, Issue 1, Pages 153-194

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jhep.2016.09.001

Keywords

-

Funding

  1. Abbvie
  2. Gilead
  3. Bristol-Myers Squibb
  4. Janssen
  5. Merck
  6. Viiv
  7. GlaxoSmithKline
  8. Abbott Molecular
  9. Qiagen
  10. Roche
  11. Siemens

Ask authors/readers for more resources

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available